Recurring Fatigue After Biologic Administration:Patient-Reported Data from the Dutch Biologic Monitor
Background: Fatigue is a common problem in immune-mediated inflammatory disease (IMID) patients, significantly impacting their quality of life. Objectives: In this study, we describe the pattern and characteristics of fatigue as a patient-reported adverse drug reaction (ADR) of biologics, and compared patient and treatment characteristics with patients reporting other ADRs or no ADRs. Methods: In this cohort event monitoring study, the description and characteristics of fatigue reported as a possible ADR in the Dutch Biologic Monitor were assessed and analysed for commonly recurring themes or... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2023 |
| Reihe/Periodikum: | van Lint , J A , Jessurun , N T , Tas , S W , Vonkeman , H E , van Doorn , M B A , Hoentjen , F , Nurmohamed , M T , van Puijenbroek , E P & van den Bemt , B J F 2023 , ' Recurring Fatigue After Biologic Administration : Patient-Reported Data from the Dutch Biologic Monitor ' , BioDrugs , vol. 37 , no. 4 , pp. 541-550 . https://doi.org/10.1007/s40259-023-00592-8 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26684803 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://pure.eur.nl/en/publications/da8379e6-6bfd-4ee4-9a6a-c2c3be0effab |
